Testimonies, • 08/09/2022 Dave Pounds - MDMA for Alcohol Use Disorder Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder Previous Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression You Might Also Like Advancing Psychedelic Policy in Europe by Tadeusz Hawrot at ALPS Conference 2023 Testimonial of Andrea Siclari, cancer patient, delivered at the EU Parliament event on 06.02.2025 Psychedelic-assisted therapies in the treatment of brain disorders - European Parliament Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression Launch of the PsychedeliCare and MEP Action Group on Psychedelics in Healthcare at the European Parliament 06.02.2025
Testimonies, • 08/09/2022 Dave Pounds - MDMA for Alcohol Use Disorder Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder Previous Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression You Might Also Like Advancing Psychedelic Policy in Europe by Tadeusz Hawrot at ALPS Conference 2023 Testimonial of Andrea Siclari, cancer patient, delivered at the EU Parliament event on 06.02.2025 Psychedelic-assisted therapies in the treatment of brain disorders - European Parliament Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression Launch of the PsychedeliCare and MEP Action Group on Psychedelics in Healthcare at the European Parliament 06.02.2025
